Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 1,113.93 | 745.25 | 909.48 | 900.18 |
Depreciation/ Depletion | 135.40 | 130.80 | 125.30 | 116.09 |
Non- Cash Items | -52.37 | 0.50 | -33.22 | -0.82 |
Changesin Working Capital | -411.89 | -84.77 | -439.52 | -439.14 |
Cashfrom Operating Activities | 785.07 | 791.78 | 562.04 | 576.31 |
Capital Expenditures | -152.41 | -174.49 | -148.84 | -171.61 |
Other Investing Cash Flow Items Total | 217.80 | -385.11 | 74.74 | -110.78 |
Cashfrom Investing Activities | 65.39 | -559.60 | -74.10 | -282.39 |
Financing Cash Flow Items | -4.45 | -3.44 | -75.87 | -40.69 |
Total Cash Dividends Paid | -642.17 | -89.69 | -82.21 | -82.90 |
Issuance( Retirement)of Stock Net | -388.27 | 0.00 | -285.59 | -135.41 |
Issuance( Retirement)of Debt Net | -16.17 | -14.74 | -16.37 | -59.29 |
Cashfrom Financing Activities | -1,051.06 | -107.87 | -460.04 | -318.29 |
Net Changein Cash | -200.60 | 124.31 | 27.90 | -24.37 |
Cash Interest Paid | 3.53 | 2.33 | 7.35 | 8.27 |
Cash Taxes Paid | 312.13 | 151.29 | 239.13 | 230.39 |
Ajanta Pharmaceuticals Dividend Ajanta Pharmaceuticals Bonus Ajanta Pharmaceuticals News Ajanta Pharmaceuticals AGM Ajanta Pharmaceuticals Rights Ajanta Pharmaceuticals Splits Ajanta Pharmaceuticals Board Meetings Ajanta Pharmaceuticals Key Metrics Ajanta Pharmaceuticals Shareholdings Ajanta Pharmaceuticals Profit Loss Ajanta Pharmaceuticals Balance Sheet Ajanta Pharmaceuticals Q1 Results Ajanta Pharmaceuticals Q2 Results Ajanta Pharmaceuticals Q3 Results Ajanta Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks